Biomea Fusion, Inc. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Biomea Fusion, Inc. (BMEA) had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $13.20 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2026-08-05
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $13.20M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $9.00M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $10.80M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $12.20M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $13.20M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $9.00M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $10.80M 10-K · filed 2026-03-24 |
| 2025-09-30 | $12.20M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $15.40M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $17.50M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $30.40M 10-K · filed 2025-03-31 |
| 2024-09-30 | $32.30M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $40.30M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $42.90M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $27.60M 10-K · filed 2024-03-28 |
| 2023-09-30 | $30.10M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $30.00M 10-Q · filed 2023-07-31 |
| 2023-03-31 | $30.50M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $25.00M 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |